Charity Accounts Intelreading the accounts so you don’t have to

BRITISH SOCIETY OF BLOOD AND MARROW TRANSPLANTATION AND CELLULAR THERAPY

Registered charity 1125795 · accounts filings on the Charity Commission register · also known as BRITISH SOCIETY OF BLOOD AND MARROW TRANSPLANTATION

To promote education and research in blood and marrow stem cell transplantation and cellular therapy in the UK and Republic of Ireland.

Causes: The Advancement Of Health Or Saving Of Lives · website · Get email alerts

Latest income
£541k
Latest spending
£533k
Registered
2008
Accounts read
FY2024

Financial health, per its FY2024 accounts

The accounts state that unrestricted reserves increased to £452,813, which is below the trustees' stated policy target of maintaining six months of operational expenditure. The trustees report that income has remained relatively flat while costs rise, creating a dependency on securing diversified funding to sustain future activities.

Automated summary of the FY2024 accounts; the evidenced findings below carry the verbatim passages.

What the accounts disclose

Reserves policy: six months (held: £453k)
“The policy of the trustees is to maintain a level of reserves that is sufficient to continue the operation of the charity's activities for six months enabling the Trustees to meet all known financial commitments and achieve a well-managed closure in the event of unforeseen changes in funding circumstances.” — page 14
Per its FY2024 accounts as filed with the Charity Commission.
Going concern: noted by the trustees or auditor
“Sufficient and sustainable funding is a prerequisite for the society's survival and success. Static income limits the society's ability to pursue new opportunities and constrains its ability to expand and improve its current offer to meet members' needs.” — page 14
Per its FY2024 accounts as filed with the Charity Commission.

Accounts independently examined (not a full audit). Discloses 5 of 6 completeness components.

Structured financials (annual return, FY ending 31/12/2024)

Total income
£541k
Total spending
£533k
Reserves (reported)
£453k
Employees
0

Reported reserves equal ~10.2 months of spending — above the median for charities its size (median 5.2 months; benchmarks).

Trustees · trustee networks

Trustee list from the Charity Commission register (current, not historical).

Operates in: Northern Ireland · Scotland · Throughout England And Wales

Income and spending

Financial year endIncomeSpending
31/12/2024£541k£533k
31/12/2023£394k£460k
31/12/2022£376k£425k
31/12/2021£342k£394k
31/12/2020£388k£335k

Common questions

Is BRITISH SOCIETY OF BLOOD AND MARROW TRANSPLANTATION AND CELLULAR THERAPY financially healthy?

Per its FY2024 accounts: The accounts state that unrestricted reserves increased to £452,813, which is below the trustees' stated policy target of maintaining six months of operational expenditure. The trustees report that income has remained relatively flat while costs rise, creating a dependency on securing diversified funding to sustain future activities. Its FY2024 accounts were independently examined.